Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

13
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
13
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

17
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
17
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

38
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
38
Angina IV: Management01:26

Angina IV: Management

12
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
12
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

36
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
36
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

18
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
18

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Direct oral anticoagulants in older patients with atrial fibrillation and comorbidities: frailty, renal impairment, acute or chronic coronary syndromes, and acute stroke.

Polish archives of internal medicine·2026
Same author

Revisiting the ISCHEMIA trial data through non-linear machine learning modelling.

European journal of preventive cardiology·2026
Same author

Aspirin vs clopidogrel in chronic coronary syndromes: a meta-analysis of ethnic differences.

European heart journal·2026
Same author

CAPIRE score predicts long-term major cardiac events.

The international journal of cardiovascular imaging·2026
Same author

Transcatheter aortic valve thrombosis.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026
Same author

Mortality score in chronic coronary syndrome: prediction model from the ISCHEMIA trial.

European journal of preventive cardiology·2026

Related Experiment Video

Updated: Aug 1, 2025

Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

789

Current concepts in coronary artery revascularisation.

Mario Gaudino1, Felicita Andreotti2, Takeshi Kimura3

  • 1Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY, USA.

Lancet (London, England)
|April 30, 2023
PubMed
Summary

Coronary revascularisation offers surgical or percutaneous options. While surgery has higher risks, it reduces future cardiac events, though medical therapy may suffice for some patients.

More Related Videos

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
06:32

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

8.0K
Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model
12:00

Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model

Published on: November 24, 2014

15.6K

Related Experiment Videos

Last Updated: Aug 1, 2025

Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

789
Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
06:32

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

8.0K
Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model
12:00

Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model

Published on: November 24, 2014

15.6K

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Coronary artery revascularisation is a key treatment for obstructive coronary artery disease.
  • Surgical revascularisation involves higher procedural risk and longer recovery than percutaneous interventions.
  • Despite benefits in reducing recurrent cardiac events, current data predominantly represent specific demographics and regions.

Purpose of the Study:

  • To review the current landscape of coronary artery revascularisation.
  • To highlight the comparative risks and benefits of surgical versus percutaneous approaches.
  • To identify critical gaps in existing research regarding diverse patient populations and global contexts.

Main Methods:

  • Review of existing literature on coronary artery revascularisation.
  • Comparison of outcomes between surgical and percutaneous interventions.
  • Analysis of patient selection criteria, including clinical, anatomical, and preference-based factors.

Main Results:

  • Surgical revascularisation offers long-term reduction in recurrent cardiac events but carries higher procedural risk and recovery time.
  • Percutaneous interventions present a lower-risk alternative with faster recovery.
  • Medical therapy alone may be a viable option for select patient subsets.
  • Existing research is heavily biased towards White, non-elderly, male populations in high-income countries.

Conclusions:

  • Patient choice, clinical presentation, and anatomical factors guide revascularisation decisions.
  • Medical therapy is an essential component of care and may be sufficient in specific cases.
  • Urgent need exists for comprehensive data on revascularisation outcomes in women, older adults, minorities, and low- to middle-income countries.